about
Worldwide trends in mortality from biliary tract malignancies.Gemcitabine-based chemotherapy for advanced biliary tract carcinomasPhase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.Circulating MicroRNAs as Biomarkers in Biliary Tract CancersMicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentPalliative Endoscopic Treatment Options in Malignancies of the Biliopancreatic SystemTargeted Therapy in Biliary Tract CancersResectable Cholangiocarcinoma: Reviewing the Role of Adjuvant StrategiesOptimum chemotherapy for the management of advanced biliary tract cancerThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsEndoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic ReviewA proteomic analysis of human bileTelomeres and telomere dynamics: relevance to cancers of the GI tractIgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decadesPhotodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma.Endoscopic ultrasonography can diagnose distal biliary strictures without a mass on computed tomography.Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival.Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data.Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma.Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial)Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerGemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancerA phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.Intrahepatic cholangiocarcinomaMultivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic functionSorafenib in patients with advanced biliary tract carcinoma: a phase II trial.In-hospital mortality after resection of biliary tract cancer in the United States.
P2860
Q21093310-E9E7589A-92E8-4898-B943-29CE01FE7248Q24187573-814A6A5D-013B-44F1-AE14-11F6BCEA7A5DQ24814067-8DD3FEB0-1ED3-4CBA-BD14-CE632C6A9AB6Q26746000-E562DB1F-4CD8-42D2-A12F-F07AC9E33659Q26783579-A25FE467-D84E-441D-A007-BDFF452E730AQ26796526-301C7AC1-A619-4417-BC1B-87CFA1FDC5D5Q26798443-FE2E1093-3FC9-4FE3-B9D6-B444673BFBF2Q26849394-B2ADAFAB-9FEA-4AEF-AD6E-86FD6B049353Q27010873-F665707A-E3AD-45D7-9829-D35E85CCF7BAQ27340125-7E5414D9-39B8-441D-A821-6BB4E4EDDA9DQ28075370-06E19148-27C1-477D-BD4D-AE43F8B76F3CQ28256550-EDE48FD8-1C1C-41CA-A076-95AAE13D3414Q28394311-7C499BCE-555A-491F-A082-39AC47764378Q30279247-8FB30B26-1661-4429-93B3-AA3098D528E2Q30300756-A55696FA-69F0-4EAF-8EB5-6B836DD09186Q30433853-F616C9C8-7300-4ECD-BA26-705885C734D0Q30483947-C0DACE1B-189D-4EFA-BB07-3AEDE22CBA4FQ30835874-B8B94730-A0E3-49BB-ABB3-7F4134F3BCF3Q31032714-765C43AB-4C12-431C-8A09-BB80FAD7DE07Q31033443-2283D286-0046-4301-B24B-B49A80B3D989Q31090122-A3F9FB8E-2F96-43B9-9AC0-CAA77252F41EQ33212427-7A128751-DAA2-447D-A6C7-4657F91AF9E9Q33277947-ED45DB03-80EA-444B-BD1B-2256907F4838Q33286698-AE4BC7BA-E67E-4F39-93BC-C62D8027DF41Q33360400-3EB7BE95-2309-4116-A90F-0BD97C5DB969Q33360849-6976AAD3-AFB8-4535-B3B2-616B22F4D55AQ33371325-466E7CCF-6DC4-4068-BA0D-CEE1CC7D3887Q33372640-9BFD7F48-5CA6-40B3-9CF6-5251E7D540A0Q33383423-9E49CA66-886A-4519-BA9B-6AB323926A2BQ33384257-4B90CBA9-D1A6-4733-A700-89C1FAB6B61CQ33392476-987135BB-DE39-4143-822E-FE05E4889E0CQ33398969-67D00316-6011-45EE-9F4A-E3DEB4A3E425Q33399656-EFC7B395-73E8-4F6F-986C-29B00A3EC2D4Q33401071-129FAB7B-85C6-44B9-99CA-CA20C610E6E8Q33420043-0AFE468C-25EE-4E21-BA75-4CB8E30AE66EQ33555135-474A9801-3A0D-4EFA-B063-48A90907EADDQ33555296-C2B59B05-1197-4AB6-BBF1-22631954753DQ33593207-53E6AAE3-D545-4741-AE10-4D22ECF2E1ACQ33620083-3F48FE9D-97D1-4239-8EB1-2F3EEAF5F80CQ33622816-38D0657A-D972-46DA-BC5C-6B014FF0FA38
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Biliary tract cancers.
@ast
Biliary tract cancers.
@en
type
label
Biliary tract cancers.
@ast
Biliary tract cancers.
@en
prefLabel
Biliary tract cancers.
@ast
Biliary tract cancers.
@en
P2093
P1476
Biliary tract cancers.
@en
P2093
Gunderson LL
LaRusso NF
Nagorney DM
de Groen PC
P304
P356
10.1056/NEJM199910283411807
P407
P577
1999-10-01T00:00:00Z